CINDI BODERMAN: Open Payments
NPI 1164968608 · BLUFFTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,085 in 94 payments from 16 companies in 2025. Trend: 2023 $17 · 2024 $2,419 · 2025 $2,085
Food & beverage: $2,085
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $545 |
| Novartis Pharmaceuticals Corporation | 10 | $268 |
| Janssen Biotech, Inc. | 12 | $222 |
| Mallinckrodt Hospital Products Inc. | 9 | $199 |
| Lilly USA, LLC | 7 | $163 |
| E.R. Squibb & Sons, L.L.C. | 10 | $156 |
| GlaxoSmithKline, LLC. | 3 | $74 |
| ANI Pharmaceuticals, Inc. | 3 | $71 |
| Aurinia Pharma U.S., Inc. | 3 | $68 |
| Genentech USA, Inc. | 3 | $64 |
Products named: RINVOQ, COSENTYX, TREMFYA, SKYRIZI, ACTHAR, TALTZ, ORENCIA, BENLYSTA.
Industry payments across SC — which companies pay providers there.
